Mark Cooper
Mark Cooper
Department of Diabetes, Monash University
Verified email at monash.edu
Title
Cited by
Cited by
Year
Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy
BM Brenner, ME Cooper, D De Zeeuw, WF Keane, WE Mitch, HH Parving, ...
New England journal of medicine 345 (12), 861-869, 2001
81902001
A trial of darbepoetin alfa in type 2 diabetes and chronic kidney disease
MA Pfeffer, EA Burdmann, CY Chen, ME Cooper, D De Zeeuw, ...
New England Journal of Medicine 361 (21), 2019-2032, 2009
19782009
Mechanisms of diabetic complications
JM Forbes, ME Cooper
Physiological reviews 93 (1), 137-188, 2013
17832013
Randomised controlled trial of dual blockade of renin-angiotensin system in patients with hypertension, microalbuminuria, and non-insulin dependent diabetes: the candesartan …
CE Mogensen, S Neldam, I Tikkanen, S Oren, R Viskoper, RW Watts, ...
Bmj 321 (7274), 1440-1444, 2000
15042000
Pathophysiology and treatment of type 2 diabetes: perspectives on the past, present, and future
SE Kahn, ME Cooper, S Del Prato
The Lancet 383 (9922), 1068-1083, 2014
13592014
Oxidative stress as a major culprit in kidney disease in diabetes
JM Forbes, MT Coughlan, ME Cooper
Diabetes 57 (6), 1446-1454, 2008
12082008
1 Happy Objects
S Ahmed
The affect theory reader, 29-51, 2010
10852010
Proteinuria, a target for renoprotection in patients with type 2 diabetic nephropathy: lessons from RENAAL
D De Zeeuw, G Remuzzi, HH Parving, WF Keane, Z Zhang, S Shahinfar, ...
Kidney international 65 (6), 2309-2320, 2004
10782004
The role of advanced glycation end products in progression and complications of diabetes
SY Goh, ME Cooper
The Journal of Clinical Endocrinology & Metabolism 93 (4), 1143-1152, 2008
10612008
Transient high glucose causes persistent epigenetic changes and altered gene expression during subsequent normoglycemia
A El-Osta, D Brasacchio, D Yao, A Pocai, PL Jones, RG Roeder, ...
The Journal of experimental medicine 205 (10), 2409-2417, 2008
10162008
Albuminuria, a therapeutic target for cardiovascular protection in type 2 diabetic patients with nephropathy
D De Zeeuw, G Remuzzi, HH Parving, WF Keane, Z Zhang, S Shahinfar, ...
Circulation 110 (8), 921-927, 2004
9182004
Albuminuria and kidney function independently predict cardiovascular and renal outcomes in diabetes
T Ninomiya, V Perkovic, BE De Galan, S Zoungas, A Pillai, M Jardine, ...
Journal of the American Society of Nephrology 20 (8), 1813-1821, 2009
8892009
Reduced bone mass in daughters of women with osteoporosis
E Seeman, JL Hopper, LA Bach, ME Cooper, E Parkinson, J McKay, ...
New England Journal of Medicine 320 (9), 554-558, 1989
7961989
Development of drought-resistant cultivars using physiomorphological traits in rice
S Fukai, M Cooper
Field Crops Research 40 (2), 67-86, 1995
7811995
Sildenafil improves exercise capacity and quality of life in patients with systolic heart failure and secondary pulmonary hypertension
GD Lewis, R Shah, K Shahzad, J Camuso, PP Pappagianopoulos, ...
Journal of Cardiac Failure 13 (6), S135-S136, 2007
777*2007
The tubulointerstitium in progressive diabetic kidney disease: more than an aftermath of glomerular injury?
RE Gilbert, ME Cooper
Kidney international 56 (5), 1627-1637, 1999
7671999
Pathogenesis, prevention, and treatment of diabetic nephropathy
ME Cooper
The Lancet 352 (9123), 213-219, 1998
7061998
Improving drought tolerance in maize: a view from industry
H Campos, M Cooper, JE Habben, GO Edmeades, JR Schussler
Field crops research 90 (1), 19-34, 2004
6612004
Can changes in canopy and/or root system architecture explain historical maize yield trends in the US corn belt?
GL Hammer, Z Dong, G McLean, A Doherty, C Messina, J Schussler, ...
Crop Science 49 (1), 299-312, 2009
6352009
Follow-up of blood-pressure lowering and glucose control in type 2 diabetes
S Zoungas, J Chalmers, B Neal, L Billot, Q Li, Y Hirakawa, H Arima, ...
New England Journal of Medicine 371 (15), 1392-1406, 2014
6062014
The system can't perform the operation now. Try again later.
Articles 1–20